Vedtægter for Novo Nordisk, april 2024
April 24, 2024 08:57 ET
|
Novo Nordisk A/S
Vedtægter for Novo Nordisk, april 2024
Vedhæftet fil
Vedtægter 24 Apr 2024
...
Novo Nordisk A/S - Articles of Association, April 2024
April 24, 2024 08:57 ET
|
Novo Nordisk A/S
Novo Nordisk's Articles of Association, April 2024
Attachment
Articles of Association 24 Apr 2024
...
Novo Nordisk A/S – Reduction of the share capital
April 24, 2024 08:48 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 24 April 2024 – At Novo Nordisk’s Annual General Meeting on 21 March 2024, it was decided to reduce the company’s B share capital from DKK 343,512,800 to DKK 339,012,800 by...
Novo Nordisk A/S - share repurchase programme
April 22, 2024 09:06 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 22 April 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
April 15, 2024 13:39 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 15 April 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated...
Novo Nordisk A/S - share repurchase programme
April 15, 2024 08:43 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 15 April 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Novo Nordisk A/S - share repurchase programme
April 08, 2024 09:40 ET
|
Novo Nordisk A/S
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 08 April 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No...
Novo Nordisk A/S - share repurchase programme
April 02, 2024 06:56 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 2 April 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Novo Nordisk A/S - share repurchase programme
March 25, 2024 07:58 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 25 March 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Novo Nordisk to acquire Cardior Pharmaceuticals and strengthen pipeline in cardiovascular disease
March 25, 2024 05:59 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, and Hannover, Germany, 25 March, 2024 – Novo Nordisk and Cardior Pharmaceuticals today announced that Novo Nordisk has agreed to acquire Cardior for up to 1.025 billion Euros,...